Reviva Pharmaceuticals (RVPH) Short Interest Ratio & Short Volume → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free RVPH Stock Alerts $1.71 +0.01 (+0.54%) (As of 12:07 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Reviva Pharmaceuticals Short Interest DataCurrent Short Volume1,250,000 sharesPrevious Short Volume1,230,000 sharesChange Vs. Previous Month+1.63%Dollar Volume Sold Short$3.83 millionShort Interest Ratio / Days to Cover4.6Last Record DateApril 30, 2024Outstanding Shares27,920,000 sharesPercentage of Shares Shorted4.48%Today's Trading Volume236,185 sharesAverage Trading Volume306,806 sharesToday's Volume Vs. Average77% Short Selling Reviva Pharmaceuticals ? Sign up to receive the latest short interest report for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRVPH Short Interest Over TimeRVPH Days to Cover Over TimeRVPH Percentage of Float Shorted Over Time Ad Paradigm PressBiden FINISHED On June 13th?Thanks to Biden’s disgraceful leadership we now have sky-high inflation… unchecked immigration… rampant crime… and a “woke mob” hell bent on destroying the America you and I know and love. Biden’s days are numbered.Click here now to see his shocking evidence. Reviva Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,250,000 shares $3.83 million +1.6%N/A4.6 $3.06 4/15/20241,230,000 shares $4.28 million +16.0%N/A4.1 $3.48 3/31/20241,060,000 shares $4.01 million +62.9%N/A3.2 $3.78 3/15/2024650,700 shares $2.05 million -24.2%N/A1.5 $3.15 2/29/2024858,100 shares $3.27 million -15.9%N/A2 $3.81 2/15/20241,020,000 shares $4.38 million +21.5%N/A2.3 $4.29 Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024839,800 shares $3.26 million +14.7%N/A1.6 $3.88 1/15/2024732,400 shares $3.05 million -20.9%N/A0.6 $4.17 12/31/2023925,900 shares $4.77 million +2.6%N/A0.7 $5.15 12/15/2023902,300 shares $3.41 million -47.5%N/A0.7 $3.78 11/30/20231,720,000 shares $6.59 million -48.0%N/A1.5 $3.83 11/15/20233,310,000 shares $16.55 million +30.8%N/A3 $5.00 10/31/20232,530,000 shares $11.87 million +42.9%N/A2.5 $4.69 10/15/20231,770,000 shares $7.98 million +5.4%N/A9.8 $4.51 9/30/20231,680,000 shares $8.20 million +14.3%N/A10.4 $4.88 9/15/20231,470,000 shares $8.01 million +14.0%N/A8.9 $5.45 8/31/20231,290,000 shares $5.04 million -2.3%N/A7.3 $3.91 8/15/20231,320,000 shares $5.64 million +4.8%N/A6.7 $4.27 7/31/20231,260,000 shares $5.97 million +1.6%N/A6.4 $4.74 7/15/20231,240,000 shares $6.31 million No ChangeN/A5.2 $5.09 6/30/20231,240,000 shares $7.27 million -18.4%N/A5.4 $5.86 6/15/20231,520,000 shares $9.45 million -1.9%N/A7.3 $6.22 5/31/20231,550,000 shares $9.47 million -4.9%N/A8.4 $6.11 5/15/20231,630,000 shares $13.02 million +20.7%N/A10.8 $7.99 4/30/20231,350,000 shares $9.25 million +22.7%N/A9.8 $6.85 4/15/20231,100,000 shares $5.26 million +11.9%N/A10 $4.78 3/31/2023982,800 shares $4.12 million +13.9%N/A10.1 $4.19 3/15/2023863,200 shares $3.45 million +9.8%N/A7 $4.00 2/28/2023786,500 shares $3.69 million +0.4%N/A5.3 $4.69 2/15/2023783,200 shares $3.54 million -5.3%N/A4.6 $4.53 1/31/2023827,100 shares $3.94 million -11.9%N/A3.4 $4.76 1/15/2023938,300 shares $4.12 million -2.6%N/A2.8 $4.39 12/30/2022963,400 shares $4.09 million -6.5%N/A2.2 $4.25 12/15/20221,030,000 shares $4.23 million No ChangeN/A2.2 $4.11 11/30/20221,030,000 shares $3.78 million -15.6%N/A1.9 $3.67 11/15/20221,220,000 shares $4.84 million +49.4%N/A0.9 $3.97 10/31/2022816,600 shares $3.20 million -8.4%N/A0.5 $3.92 10/15/2022891,100 shares $3.15 million +24.1%N/A0.5 $3.54 9/30/2022717,800 shares $1.14 million -9.9%N/A0.5 $1.59 9/15/2022796,300 shares $1.86 million -20.4%N/A0.5 $2.34Biden to Drop BOMBSHELL June 13th? (Ad)Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th!Click here now to see his shocking evidence. RVPH Short Interest - Frequently Asked Questions What is Reviva Pharmaceuticals' current short interest? Short interest is the volume of Reviva Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 1,250,000 shares of RVPH short. Learn More on Reviva Pharmaceuticals' current short interest. What is a good short interest ratio for Reviva Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RVPH shares currently have a short interest ratio of 5.0. Learn More on Reviva Pharmaceuticals's short interest ratio. Which institutional investors are shorting Reviva Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Reviva Pharmaceuticals: Citadel Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Reviva Pharmaceuticals' short interest increasing or decreasing? Reviva Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,250,000 shares, an increase of 1.6% from the previous total of 1,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Reviva Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Reviva Pharmaceuticals: Anebulo Pharmaceuticals, Inc. (0.19%), Leap Therapeutics, Inc. (5.57%), Affimed (1.54%), SELLAS Life Sciences Group, Inc. (12.10%), Tempest Therapeutics, Inc. (9.42%), LifeVantage Co. (0.78%), vTv Therapeutics Inc. (3.18%), Hookipa Pharma Inc (0.91%), Jaguar Health, Inc. (5.19%), Corvus Pharmaceuticals, Inc. (3.69%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Reviva Pharmaceuticals stock? Short selling RVPH is an investing strategy that aims to generate trading profit from Reviva Pharmaceuticals as its price is falling. RVPH shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Reviva Pharmaceuticals? A short squeeze for Reviva Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RVPH, which in turn drives the price of the stock up even further. How often is Reviva Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RVPH, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ANEB Short Interest Data LPTX Short Interest Data AFMD Short Interest Data SLS Short Interest Data TPST Short Interest Data LFVN Short Interest Data VTVT Short Interest Data HOOK Short Interest Data JAGX Short Interest Data CRVS Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RVPH) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable Prosperity